Durable response of chemotherapy for cancer of unknown primary with unfavorable subset developed in retroperitoneal space.
Atsuki MatsukawaTaigo KatoFuki KondoKeisuke KawasakiAtsunari KawashimaHiroshi KiuchiRyoichi ImamuraMotohide UemuraShinichiro FukuharaEiichi MoriiNorio NonomuraPublished in: IJU case reports (2021)
Site-specific therapy based on careful immunohistochemical tests may improve the efficacy for carcinoma of unknown primary site patients with unfavorable prognosis subset.